Nissay Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.8M Sell
74,101
-121
-0.2% -$9.46K 0.03% 298
2025
Q1
$5.38M Sell
74,222
-614
-0.8% -$44.5K 0.04% 305
2024
Q4
$5.66M Sell
74,836
-1,650
-2% -$125K 0.03% 295
2024
Q3
$5.05M Buy
76,486
+2,220
+3% +$146K 0.03% 313
2024
Q2
$6.86M Sell
74,266
-1,083
-1% -$100K 0.05% 249
2024
Q1
$7.2M Buy
75,349
+639
+0.9% +$61.1K 0.05% 233
2023
Q4
$5.7M Buy
74,710
+2,602
+4% +$198K 0.05% 232
2023
Q3
$5M Buy
72,108
+2,467
+4% +$171K 0.04% 236
2023
Q2
$6.57M Sell
69,641
-2,478
-3% -$234K 0.06% 199
2023
Q1
$5.97M Sell
72,119
-2,434
-3% -$201K 0.05% 202
2022
Q4
$5.56M Sell
74,553
-2,171
-3% -$162K 0.05% 216
2022
Q3
$6.34M Buy
76,724
+2,246
+3% +$186K 0.07% 177
2022
Q2
$7.08M Sell
74,478
-2,730
-4% -$260K 0.07% 162
2022
Q1
$9.09M Buy
77,208
+1,633
+2% +$192K 0.08% 150
2021
Q4
$9.79M Buy
75,575
+5,208
+7% +$675K 0.08% 158
2021
Q3
$7.97M Buy
70,367
+2,032
+3% +$230K 0.07% 167
2021
Q2
$7.08M Buy
68,335
+1,403
+2% +$145K 0.06% 185
2021
Q1
$5.6M Sell
66,932
-1,347
-2% -$113K 0.06% 199
2020
Q4
$6.23M Sell
68,279
-2,430
-3% -$222K 0.09% 176
2020
Q3
$5.64M Sell
70,709
-11,759
-14% -$939K 0.1% 174
2020
Q2
$5.7M Sell
82,468
-1,394
-2% -$96.3K 0.11% 181
2020
Q1
$5.27M Buy
83,862
+4,839
+6% +$304K 0.13% 159
2019
Q4
$6.15M Sell
79,023
-2,949
-4% -$229K 0.14% 174
2019
Q3
$6.01M Sell
81,972
-2,778
-3% -$204K 0.15% 165
2019
Q2
$5.22M Sell
84,750
-2,580
-3% -$159K 0.13% 174
2019
Q1
$5.57M Sell
87,330
-5,052
-5% -$322K 0.15% 165
2018
Q4
$4.72M Buy
92,382
+3,342
+4% +$171K 0.14% 180
2018
Q3
$5.17M Buy
89,040
+1,773
+2% +$103K 0.14% 180
2018
Q2
$4.23M Sell
87,267
-4,440
-5% -$215K 0.12% 204
2018
Q1
$4.27M Sell
91,707
-4,746
-5% -$221K 0.13% 200
2017
Q4
$3.62M Buy
+96,453
New +$3.62M 0.11% 240